| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/03/2009 | WO2009043469A3 Use of pneumadin as a therapeutic agent |
| 09/03/2009 | WO2009043466A3 Therapeutic use of the peptide gluten exorphin a5 |
| 09/03/2009 | WO2009043455A3 Therapeutic uses of angiogenin 108-122 and gluten exorphin a5 |
| 09/03/2009 | WO2009040754A3 Polymorphs of s-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic acid lysine salt |
| 09/03/2009 | WO2009040018A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009040017A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009039993A3 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039992A3 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039988A3 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
| 09/03/2009 | WO2009039229A3 Method of conferring a protective immune response to norovirus |
| 09/03/2009 | WO2009033805A3 Use of somatostatin-14 as a therapeutic agent |
| 09/03/2009 | WO2009033802A3 Antide as a therapeutic agent |
| 09/03/2009 | WO2009033801A3 Syndyphalin alone or in combination with antide as a therapeutic agent |
| 09/03/2009 | WO2009033755A3 Use of l-carnosine as a therapeutic agent |
| 09/03/2009 | WO2009033741A3 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 09/03/2009 | WO2009033737A3 Use of gluten exorphin c : as a therapeutic agent |
| 09/03/2009 | WO2009033731A3 Use of a laminin peptide as a therapeutic agent |
| 09/03/2009 | WO2009033723A3 Use of aip2 as a therapeutic agent |
| 09/03/2009 | WO2009033714A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009033692A3 Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents |
| 09/03/2009 | WO2009033665A3 Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent |
| 09/03/2009 | WO2009033656A3 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
| 09/03/2009 | WO2009021121A3 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto |
| 09/03/2009 | WO2006113204A3 Thymidine derivatives for treatmemt of kaposi's sarcoma |
| 09/03/2009 | US20090221989 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid composition |
| 09/03/2009 | US20090221716 Composition Comprising At Least 3 Different Diols |
| 09/03/2009 | US20090221708 Medicinal preparation |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221666 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth |
| 09/03/2009 | US20090221655 Antibacterial agents |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221624 4-aminoquinoline compounds for treating virus-related conditions |
| 09/03/2009 | US20090221598 Use of Sanglifehrin in HCV |
| 09/03/2009 | US20090221571 Hiv integrase inhibitors |
| 09/03/2009 | US20090221568 Synthesis of Inhibitors of FtsZ |
| 09/03/2009 | US20090221565 8-Fluoro-3-methyl-6-oxo-9-[(R)-3-(thiazol-2-ylamino)-pyrrolidin-1-yl]-2,3-dihydro-6H-1-oxa-3,3a-diaza-phenalene-5-carboxylic acid; can be solid or liquid |
| 09/03/2009 | US20090221559 Benzodiazepines as hcv inhibitors |
| 09/03/2009 | US20090221523 North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| 09/03/2009 | US20090221487 Polyethlene glycol modifications of thymosin alpha-1 |
| 09/03/2009 | US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation |
| 09/03/2009 | US20090221471 Prodrugs of vancomycin with hydrolysis resistant polymer linkages |
| 09/03/2009 | US20090221470 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 09/03/2009 | US20090220595 Combination of erythropoietin glycoisoforms |
| 09/03/2009 | US20090220588 Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity |
| 09/03/2009 | US20090220574 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 09/03/2009 | US20090220550 Vaccines for Mycoplasma bovis and methods of use |
| 09/03/2009 | US20090220549 Reagents for recombinogenic engineering and use thereof |
| 09/03/2009 | US20090220548 Immunogenic Agents Against Burkholderia Psudomallei And/Or Burkholderia Mallei, Comprising Lipopolysaccharide, Capsular Polysaccharide And/Or Proteins From Burkholderia Pseudomallei |
| 09/03/2009 | US20090220547 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 09/03/2009 | US20090220546 Adjuvanted influenza vaccines for pediatric use |
| 09/03/2009 | US20090220542 Vaccine comprised specifically of protein subunits of human immunodeficiency virus's glycoprotein 120 probe to prevent and treat an infection caused by the human immunodeficiency virus |
| 09/03/2009 | US20090220539 Recombinant Mononegaviral Virus Vectors |
| 09/03/2009 | US20090220538 vaccine for staphylococcal infections |
| 09/03/2009 | US20090220522 Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof |
| 09/03/2009 | US20090220519 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 09/03/2009 | US20090220514 ADAM10 and its Uses Related to Infection |
| 09/03/2009 | US20090220490 Compositions and Assays for Inhibiting HCV Infection |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | US20090220456 Uses of interferons with altered spatial structure |
| 09/03/2009 | US20090220440 Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections |
| 09/03/2009 | DE102004028899B4 Verwendung einer Kombination zur präventiven und/oder therapeutischen Behandlung von bakteriell bedingten Infektionserkrankungen oder der Sepsis Using a combination of preventive and / or therapeutic treatment of bacterial infectious diseases or sepsis |
| 09/03/2009 | CA2717036A1 Methods for prognosing the status of tumor patients |
| 09/03/2009 | CA2716971A1 Chemical compounds having antiviral activity against dengue virus and other flaviviruses |
| 09/03/2009 | CA2716720A1 Pharmaceutical composition |
| 09/03/2009 | CA2716365A1 Heterocyclic urea derivatives and methods of use thereof-211 |
| 09/03/2009 | CA2715728A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolone, prep aration thereof and use thereof as anti-bacterials |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096438A1 Methods for prognosing the status of patients |
| 09/02/2009 | EP2096117A1 Process for producing erythromycin derivative |
| 09/02/2009 | EP2095827A1 High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/02/2009 | EP2094711A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 09/02/2009 | EP2094702A2 Viral inhibitors |
| 09/02/2009 | EP2094682A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 09/02/2009 | EP2094660A2 Immunochemically equivalent hiv drug analogs |
| 09/02/2009 | EP2094358A2 Imidazoles for treating multi-drug resistant bacterial infections |
| 09/02/2009 | EP2094309A2 Alpha-lactalbumin composition |
| 09/02/2009 | EP2094301A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |
| 09/02/2009 | EP2094300A1 Medicinal formulation for the treatment for hepatitis c |
| 09/02/2009 | EP2094282A2 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 09/02/2009 | EP2094279A2 Methods and compositions for treating influenza |
| 09/02/2009 | EP2094273A1 Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection |
| 09/02/2009 | EP2094267A2 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 09/02/2009 | EP2094264A1 Clotrimazol for treating staphylococcal infections |
| 09/02/2009 | EP2094091A2 Antimicrobial composition |
| 09/02/2009 | EP1902037B1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 09/02/2009 | EP1888574B1 New antibiotic derivatives |
| 09/02/2009 | EP1850913B1 Substance for the treatment of infections |
| 09/02/2009 | EP1581535B3 Pyrrolopyridazine derivatives |
| 09/02/2009 | EP1501527B1 Use of mastic and its essential oils for the control of microbial infections |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1456229B1 Method for preparing echinocandin derivatives |
| 09/02/2009 | EP1411913A4 Antimicrobial nanoemulsion compositions and methods |
| 09/02/2009 | EP1326584B1 Delivery system and method of treating or preventing otitis media |
| 09/02/2009 | EP1309333B1 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 09/02/2009 | EP1189645B1 Non-covalent bioconjugates useful for diagnosis and therapy |
| 09/02/2009 | EP1005368B1 Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants |
| 09/02/2009 | EP0975597B1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 09/02/2009 | CN101519651A Shigella flexneri phage strain and application thereof |
| 09/02/2009 | CN101519440A Intersecting protective vaccine antigen, preparation method and application thereof |